{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:17:05Z","timestamp":1778152625967,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000703"],"award-info":[{"award-number":["82000703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470726"],"award-info":[{"award-number":["82470726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and technology development fund of Affiliated Hospital of Xuzhou Medical University","award":["XYFY2020038"],"award-info":[{"award-number":["XYFY2020038"]}]},{"name":"Science and technology development fund of Affiliated Hospital of Xuzhou Medical University","award":["XYFC2020001"],"award-info":[{"award-number":["XYFC2020001"]}]},{"name":"Xuzhou Basic Research Program","award":["KC22042"],"award-info":[{"award-number":["KC22042"]}]},{"name":"The Open Project of Key Laboratory of Higher Education Institutions in Jiangsu Province","award":["XZSYSKF2023019"],"award-info":[{"award-number":["XZSYSKF2023019"]}]},{"name":"Beanstalk talent of Affiliated Hospital of Xuzhou Medical University"},{"name":"the Jiangsu Provincial Natural Science Foundation","award":["BK20211054"],"award-info":[{"award-number":["BK20211054"]}]},{"name":"The High-Level Hospital Construction Project of Jiangsu Province","award":["LCZX202403"],"award-info":[{"award-number":["LCZX202403"]}]},{"name":"Paired Assistance Scientific Research Project by The Affiliated Hospital of Xuzhou Medical University","award":["SHJDBF2024104"],"award-info":[{"award-number":["SHJDBF2024104"]}]},{"name":"Xuzhou Medical leading Talent training Project","award":["XWRCHT20210038"],"award-info":[{"award-number":["XWRCHT20210038"]}]},{"name":"the New Technology project of Affiliated Hospital of Xuzhou Medical University","award":["2020301018"],"award-info":[{"award-number":["2020301018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04894-1","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:56:43Z","timestamp":1774713403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of serums HIF-1\u03b1 and HIF-2\u03b1 with the levels and severity of renal fibrosis: a retrospective cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuf Abdulkarim","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"4894_CR1","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12:e382\u201395.","journal-title":"Lancet Glob Health"},{"issue":"10075","key":"4894_CR2","first-page":"1238","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, et al. Chronic Kidney Disease Lancet. 2017;389(10075):1238\u201352.","journal-title":"Chronic Kidney Disease Lancet"},{"key":"4894_CR3","doi-asserted-by":"crossref","unstructured":"Ulasi II, Awobusuyi O, Nayak S, Ramachandran R, Musso, Carlos G. Chronic Kidney disease burden in low-resource settings: regional perspectives. Sem Nephrol. 2023.","DOI":"10.1016\/j.semnephrol.2023.151336"},{"key":"4894_CR4","doi-asserted-by":"crossref","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z. Naicker, Saraladevi. Chronic kidney disease: global dimension and perspectives. Lancet (London England). 2013;382(9888).","DOI":"10.1016\/S0140-6736(13)60687-X"},{"key":"4894_CR5","doi-asserted-by":"crossref","unstructured":"Fine GL, Bandyopadhay D, Norman TJ. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia [J]. Kidney Int. 2000;S5722\u201326.","DOI":"10.1046\/j.1523-1755.2000.07512.x"},{"key":"4894_CR6","doi-asserted-by":"publisher","unstructured":"Liu Y. Kidney fibrosis: fundamental questions, challenges, and perspectives. Integr Med Nephrol Androl 11(4):e24-00027. https:\/\/doi.org\/10.1097\/IMNA-D-24-00027.","DOI":"10.1097\/IMNA-D-24-00027"},{"key":"4894_CR7","doi-asserted-by":"crossref","unstructured":"Taherian M, Taherian M, Bayati P, Bayati P, Mojtabavi N. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways. Stem Cell Res Ther. 2024.","DOI":"10.1186\/s13287-024-03782-5"},{"key":"4894_CR8","doi-asserted-by":"crossref","unstructured":"Feng X, Zhang J, Yang R, et al. The novel peptide PEP-Z-2 potentially treats renal fibrosis in vivo and in vitro by regulating TGF-\u03b2\/Smad\/AKT\/MAPK signaling.[J]. Eur J Pharmacol. 2024;982176942.","DOI":"10.1016\/j.ejphar.2024.176942"},{"key":"4894_CR9","doi-asserted-by":"crossref","unstructured":"Ma Y, Wang J, Fan J, et al. Interrelation of natural polyphenol and fibrosis in diabetic nephropathy[J]. Molecules. 2024;30(1):20\u201320.","DOI":"10.3390\/molecules30010020"},{"key":"4894_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fimmu.2015.00340","volume":"6","author":"PR Gajjala","year":"2015","unstructured":"Gajjala PR, Sanati M, Jankowski J. Cellular and Molecular mechanisms of chronic kidney disease with diabetes Mellitus and Cardiovascular diseases as its comorbidities. Front Immunol. 2015;6:340.","journal-title":"Front Immunol"},{"key":"4894_CR11","doi-asserted-by":"crossref","unstructured":"Chen X, Chen X, Chen X, Deli\u0107 D, Deli\u0107 D. sGC stimulator (BAY 41-8543) combined with PDE9 inhibitor (BAY 73-6691) reduces renal fibrosis in 5\/6 nephrectomized rats. Basic Clin Pharmacol Toxicol. 2024.","DOI":"10.1111\/bcpt.14103"},{"key":"4894_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ki.2008.350","volume":"74","author":"LG Fine","year":"2008","unstructured":"Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int. 2008;74:867\u201372.","journal-title":"Kidney Int"},{"key":"4894_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000381515","volume":"1","author":"S Tanaka","year":"2015","unstructured":"Tanaka S, Tanaka T, Nangaku M. Hypoxia and dysregulated angiogenesis in kidney disease. Kidney Dis (Basel). 2015;1:80\u20139.","journal-title":"Kidney Dis (Basel)"},{"key":"4894_CR14","doi-asserted-by":"crossref","unstructured":"Mimura I, Chen Z, Natarajan R. Epigenetic alterations and memory: key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 2024.","DOI":"10.1016\/j.kint.2024.10.031"},{"key":"4894_CR15","doi-asserted-by":"crossref","unstructured":"Guo Q, Chen J, Wu J, et al. Bioprinted mesenchymal stem cell microfiber-derived extracellular vesicles alleviate unilateral renal ischemia-reperfusion injury and fibrosis by inhibiting tubular epithelial cells ferroptosis[J]. Bioactive Mater. 2024;40649-664.","DOI":"10.1016\/j.bioactmat.2024.08.011"},{"key":"4894_CR16","doi-asserted-by":"crossref","unstructured":"Semenza LG. Expression of hypoxia-inducible factor 1: mechanisms and consequences[J]. Biochem Pharmacol. 2000;59(1):47\u201353.","DOI":"10.1016\/S0006-2952(99)00292-0"},{"key":"4894_CR17","doi-asserted-by":"crossref","unstructured":"Shu S, Wang Y, Zheng M, Zheng M, Liu Z. (2019). Hypoxia and hypoxia-inducible factors in kidney injury and repair. Cells. 8(3).","DOI":"10.3390\/cells8030207"},{"issue":"2","key":"4894_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/geno.1998.5416","volume":"52","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Leung SW, Semenza GL. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics. 1998;52(2):159\u201365.","journal-title":"Genomics"},{"issue":"9","key":"4894_CR19","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","volume":"94","author":"M Ema","year":"1997","unstructured":"Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA. 1997;94(9):4273\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"4894_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000449323","volume":"44","author":"N Kushida","year":"2016","unstructured":"Kushida N, Nomura S, Mimura I, Fujita T, Yamamoto S, Nangaku M, Aburatani H. Hypoxia-Inducible Factor-1\u03b1 Activates the Transforming Growth, Factor-\u03b2\/SMAD3 Pathway in Kidney Tubular Epithelial Cells. Am J Nephrol. 2016;44(4):276\u201385. https:\/\/doi.org\/10.1159\/000449323.","journal-title":"Am J Nephrol"},{"key":"4894_CR21","doi-asserted-by":"crossref","unstructured":"Zhang H, Xu R, Wang Z. (2021). Contribution of Oxidative Stress to HIF-1-Mediated profibrotic changes during the kidney damage. Oxidat Med Cell Long. 2021;6114132.","DOI":"10.1155\/2021\/6114132"},{"key":"4894_CR22","doi-asserted-by":"crossref","unstructured":"Kong HK, Oh JH, Lim JB, et al. Selective tubular activation of hypoxia-inducible factor-2\u03b1 has dual effects on renal fibrosis.[J]. Sci Rep. 2017;7(1):11351\u201311351.","DOI":"10.1038\/s41598-017-11829-2"},{"key":"4894_CR23","doi-asserted-by":"crossref","unstructured":"Naas S, Schiffer M, Sch\u00f6del J. Hypoxia and renal fibrosis. Am J Physiol. 2023.","DOI":"10.1152\/ajpcell.00201.2023"},{"issue":"1","key":"4894_CR24","doi-asserted-by":"publisher","first-page":"17630","DOI":"10.1038\/s41598-022-22636-9","volume":"12","author":"A Mima","year":"2022","unstructured":"Mima A. Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study. Sci Rep. 2022;12(1):17630. https:\/\/doi.org\/10.1038\/s41598-022-22636-9.","journal-title":"Sci Rep"},{"key":"4894_CR25","doi-asserted-by":"publisher","unstructured":"Yasuzawa T, Nakamura T, Ueshima S, Mima A. (2021). Protective effects of eicosapentaenoic acid on the glomerular endothelium via inhibition of EndMT in Diabetes. J Diab Res. 2021;2182225. https:\/\/doi.org\/10.1155\/2021\/2182225","DOI":"10.1155\/2021\/2182225"},{"key":"4894_CR26","doi-asserted-by":"crossref","unstructured":"Kapitsinou PP, Sano H, Kobayashi MM, Hanako., Davidoff O. (2014). Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Investig. 124(6).","DOI":"10.1172\/JCI69073"},{"key":"4894_CR27","doi-asserted-by":"crossref","unstructured":"Zhao H, Han Y, Jiang N, Li C, Yang M. Effects of HIF-1\u03b1 on renal fibrosis in cisplatin-induced chronic kidney disease. Clin Sci (London, England: 1979). 2021; 135(10).","DOI":"10.1042\/CS20210061"},{"issue":"3","key":"4894_CR28","first-page":"e81","volume":"105","author":"M Nangaku","year":"2007","unstructured":"Nangaku M, Inagi R, Miyata T, Fujita T. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Experimental Nephrol. 2007;105(3):e81\u201390.","journal-title":"Nephron Experimental Nephrol"},{"issue":"4","key":"4894_CR29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ki.2011.165","volume":"80","author":"T Tanaka","year":"2011","unstructured":"Tanaka T, Nangaku M, Miyata T. Hypoxia as a key player in the pathogenesis of renal diseases. Kidney Int. 2011;80(4):334\u201340.","journal-title":"Kidney Int"},{"key":"4894_CR30","doi-asserted-by":"crossref","unstructured":"Davis L, Recktenwald M, Hutt E, Fuller S, Briggs M, Goel A, Daringer N. Targeting HIF-2\u03b1 in the tumor microenvironment: redefining the role of HIF-2\u03b1 for solid cancer therapy. Cancers (Basel). 2022;14(5):1259.","DOI":"10.3390\/cancers14051259"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04894-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:06:39Z","timestamp":1778151999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04894-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4894"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04894-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committees of the participating hospital (Ethics No.XYFY2024-KL357-01). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors accept this work for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}